期刊文献+

麻疹病毒的纯化及其在麻疹IgG EIA诊断试剂中的应用 被引量:3

Purification of measles virus and its application in measles IgG EIA test system
下载PDF
导出
摘要 目的:摸索纯化麻疹病毒的方法,并以其为包被抗原,制备麻疹IgG酶联免疫(EIA)诊断试剂。方法:将L4株麻疹病毒液先后用超滤、PEG沉淀的方法进行浓缩,再分别用连续和不连续蔗糖密度梯度超速离心法进行纯化,比较不同方法纯化后的效果,最终建立制备高纯度麻疹病毒包被抗原的方法,并在此基础上制备麻疹IgG酶联免疫(EIA)诊断试剂。结果:用超滤、PEG沉淀及连续蔗糖密度梯度超速离心纯化后的麻疹病毒的比活性为775.76 HAU/mg,SDS-PAGE及Western-blot证明纯化产物的纯度符合要求,电镜结果显示纯化物中含大量麻疹病毒。以该纯化抗原制备的EIA检测试剂与血凝抑制实验(HI)相比,该试剂的灵敏度为99.46%,特异度为81.82%,一致性为97.58%。与SIGMA麻疹IgG EIA诊断试剂盒的一致率为95.12%。结论:采用超滤、PEG沉淀及连续蔗糖密度梯度超速离心的方法可制备满足麻疹IgG EIA诊断试剂要求的包被抗原。 Objective:To develop a method for preparation of coating antigen in measles IgG EIA test system. Methods:Measles virus IA strain tissue cultures was concentrated by ultrafiltration and PEG precipitation in order, the concentrated solution was then purified by continuous and discontinuous sucrose density gradient ultracentrifugation respectively. The purified results by deferent methods were compared and the final preparing methods established in purifying measles virus IA antigen. Results:The specific activities of IA measles virus purified by ultrafiltration, PEG precipitation and continuous sucrose density gradient ultracentrifugation was 775.76 HAU/mg. The purity of the purified virus was determined by SDS - PAGE and Western - blot. Typical measles virus particles were observed by transmission electron microscope in the purified viruses solution. As compared with hemagglutination -inhibitation(HI) test, the sensitivity of the kit which used purified IA measles virus as coating antigen to detect anti - measles IgG was 99. 46%, the specificity was 81.82%, and agreement was 97.58%. The agreement with SIGMA anti - measles IgG EIA kit was 95.12%. Conclusion:We can prepare the coating antigen in measles IgG EIA test system by continuous sucrose density gradient ultracentrifugation.
出处 《中国卫生检验杂志》 CAS 2007年第4期618-621,共4页 Chinese Journal of Health Laboratory Technology
关键词 IA株麻疹病毒 酶联免疫(EIA) 包被抗原 蔗糖密度梯度超速离心 IA measles virus EIA Coating antigen Sucrose density gradient ultracentrifugation
  • 相关文献

参考文献8

二级参考文献32

共引文献111

同被引文献19

  • 1芦起,谢正德,申昆玲.呼吸道合胞病毒的蛋白特征及抗原变异[J].国外医学(病毒学分册),2005,12(3):76-80. 被引量:2
  • 2徐霞,唐晓华,黄宏,梁柳,何倚力.不同免疫方案制备鼠抗PBP2a多克隆抗体的比较[J].热带医学杂志,2007,7(2):145-147. 被引量:5
  • 3俞建昆 谢忠平 董承红 等.PEG沉淀HAV的最佳条件.中国生物制品学杂志,1997,10(1):52-52. 被引量:5
  • 4Crowe JE Jr. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development. Vaccine, 1995,13 (4): 415-421. 被引量:1
  • 5Sakurai H, Williamson RA, Crowe JE, et al. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J Virol, 1999, 73 (4): 2956-2962. 被引量:1
  • 6Tristram DA, Welliver RC, Hogerman DA, ct al. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody sistence and possible disease enhancement. Vaccine, 1994, 12 (6): 551-556. 被引量:1
  • 7Falsey AR, Walsh EE. Safety and immunogenicity of respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adult over age 60. Vaccine, 1996, 14( 13 ): 1214-1218. 被引量:1
  • 8Klinguer-Hamour C, Libon C, Plotnicky-Gilquin H, et al. DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine. Vaccine, 2002, 20 (21-22): 2743-2751. 被引量:1
  • 9国家药典委员会.中国药典(三部)[S].北京:化学工业出版社,2005附录. 被引量:4
  • 10Gruber C.,Levine S.Respiratory syncytial virus polypeptides.Ⅲ.The envelope-associated proteins.[J].J Gen Virol,1983,64(4):825-832. 被引量:1

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部